Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [21]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1110112 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Troponin I Type 3 (Cardiac) (TNNI3) antibody
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Purified
- Reactivity
- Human, Bovine, Canine, Feline, Goat, Porcine, Rabbit
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 810
- Vial size
- 1 mg
Submitted references Developmental Alterations in Heart Biomechanics and Skeletal Muscle Function in Desmin Mutants Suggest an Early Pathological Root for Desminopathies.
Characterization for binding complex formation with site-directly immobilized antibodies enhancing detection capability of cardiac troponin I.
Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients.
A caudal proliferating growth center contributes to both poles of the forming heart tube.
Single amino acid sequence polymorphisms in rat cardiac troponin revealed by top-down tandem mass spectrometry.
Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells.
Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury.
Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts.
The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro.
Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart.
Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice.
Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies.
Transfer of the full-length dystrophin-coding sequence into muscle cells by a dual high-capacity hybrid viral vector with site-specific integration ability.
Transmural stretch-dependent regulation of contractile properties in rat heart and its alteration after myocardial infarction.
Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts.
Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro.
Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component.
Calpains and cytokines in fibrillating human atria.
Antibody selection for the Abbott AxSYM troponin I assay.
Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy.
Human cardiac troponin I: precise identification of antigenic epitopes and prediction of secondary structure.
Ramspacher C, Steed E, Boselli F, Ferreira R, Faggianelli N, Roth S, Spiegelhalter C, Messaddeq N, Trinh L, Liebling M, Chacko N, Tessadori F, Bakkers J, Laporte J, Hnia K, Vermot J
Cell reports 2015 Jun 16;11(10):1564-76
Cell reports 2015 Jun 16;11(10):1564-76
Characterization for binding complex formation with site-directly immobilized antibodies enhancing detection capability of cardiac troponin I.
Cho IH, Seo SM, Jeon JW, Paek SH
Journal of biomedicine & biotechnology 2009;2009:104094
Journal of biomedicine & biotechnology 2009;2009:104094
Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients.
Pettersson K, Eriksson S, Wittfooth S, Engström E, Nieminen M, Sinisalo J
Clinical chemistry 2009 May;55(5):938-45
Clinical chemistry 2009 May;55(5):938-45
A caudal proliferating growth center contributes to both poles of the forming heart tube.
van den Berg G, Abu-Issa R, de Boer BA, Hutson MR, de Boer PA, Soufan AT, Ruijter JM, Kirby ML, van den Hoff MJ, Moorman AF
Circulation research 2009 Jan 30;104(2):179-88
Circulation research 2009 Jan 30;104(2):179-88
Single amino acid sequence polymorphisms in rat cardiac troponin revealed by top-down tandem mass spectrometry.
Sancho Solis R, Ge Y, Walker JW
Journal of muscle research and cell motility 2008;29(6-8):203-12
Journal of muscle research and cell motility 2008;29(6-8):203-12
Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells.
Hida N, Nishiyama N, Miyoshi S, Kira S, Segawa K, Uyama T, Mori T, Miyado K, Ikegami Y, Cui C, Kiyono T, Kyo S, Shimizu T, Okano T, Sakamoto M, Ogawa S, Umezawa A
Stem cells (Dayton, Ohio) 2008 Jul;26(7):1695-704
Stem cells (Dayton, Ohio) 2008 Jul;26(7):1695-704
Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury.
Lai ZF, Chen YZ, Feng LP, Meng XM, Ding JF, Wang LY, Ye J, Li P, Cheng XS, Kitamoto Y, Monzen K, Komuro I, Sakaguchi N, Kim-Mitsuyama S
American journal of physiology. Heart and circulatory physiology 2008 Aug;295(2):H708-16
American journal of physiology. Heart and circulatory physiology 2008 Aug;295(2):H708-16
Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts.
Grauss RW, van Tuyn J, Steendijk P, Winter EM, Pijnappels DA, Hogers B, Gittenberger-De Groot AC, van der Geest R, van der Laarse A, de Vries AA, Schalij MJ, Atsma DE
Stem cells (Dayton, Ohio) 2008 Apr;26(4):1083-93
Stem cells (Dayton, Ohio) 2008 Apr;26(4):1083-93
The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro.
Nishiyama N, Miyoshi S, Hida N, Uyama T, Okamoto K, Ikegami Y, Miyado K, Segawa K, Terai M, Sakamoto M, Ogawa S, Umezawa A
Stem cells (Dayton, Ohio) 2007 Aug;25(8):2017-24
Stem cells (Dayton, Ohio) 2007 Aug;25(8):2017-24
Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart.
Winter EM, Grauss RW, Hogers B, van Tuyn J, van der Geest R, Lie-Venema H, Steijn RV, Maas S, DeRuiter MC, deVries AA, Steendijk P, Doevendans PA, van der Laarse A, Poelmann RE, Schalij MJ, Atsma DE, Gittenberger-de Groot AC
Circulation 2007 Aug 21;116(8):917-27
Circulation 2007 Aug 21;116(8):917-27
Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice.
Cazorla O, Szilagyi S, Vignier N, Salazar G, Krämer E, Vassort G, Carrier L, Lacampagne A
Cardiovascular research 2006 Feb 1;69(2):370-80
Cardiovascular research 2006 Feb 1;69(2):370-80
Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies.
Eriksson S, Ilva T, Becker C, Lund J, Porela P, Pulkki K, Voipio-Pulkki LM, Pettersson K
Clinical chemistry 2005 May;51(5):848-55
Clinical chemistry 2005 May;51(5):848-55
Transfer of the full-length dystrophin-coding sequence into muscle cells by a dual high-capacity hybrid viral vector with site-specific integration ability.
Gonçalves MA, van Nierop GP, Tijssen MR, Lefesvre P, Knaän-Shanzer S, van der Velde I, van Bekkum DW, Valerio D, de Vries AA
Journal of virology 2005 Mar;79(5):3146-62
Journal of virology 2005 Mar;79(5):3146-62
Transmural stretch-dependent regulation of contractile properties in rat heart and its alteration after myocardial infarction.
Cazorla O, Szilagyi S, Le Guennec JY, Vassort G, Lacampagne A
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005 Jan;19(1):88-90
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005 Jan;19(1):88-90
Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts.
El-Armouche A, Pamminger T, Ditz D, Zolk O, Eschenhagen T
Cardiovascular research 2004 Jan 1;61(1):87-93
Cardiovascular research 2004 Jan 1;61(1):87-93
Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro.
Fukuhara S, Tomita S, Yamashiro S, Morisaki T, Yutani C, Kitamura S, Nakatani T
The Journal of thoracic and cardiovascular surgery 2003 Jun;125(6):1470-80
The Journal of thoracic and cardiovascular surgery 2003 Jun;125(6):1470-80
Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component.
Eriksson S, Junikka M, Laitinen P, Majamaa-Voltti K, Alfthan H, Pettersson K
Clinical chemistry 2003 Jul;49(7):1095-104
Clinical chemistry 2003 Jul;49(7):1095-104
Calpains and cytokines in fibrillating human atria.
Goette A, Arndt M, Röcken C, Staack T, Bechtloff R, Reinhold D, Huth C, Ansorge S, Klein HU, Lendeckel U
American journal of physiology. Heart and circulatory physiology 2002 Jul;283(1):H264-72
American journal of physiology. Heart and circulatory physiology 2002 Jul;283(1):H264-72
Antibody selection for the Abbott AxSYM troponin I assay.
Wilson DH, Laird DM, Forsythe CM, Biegalski TT, Keller AL, Herrmann RJ
Clinical chemistry 1999 Dec;45(12):2293-4
Clinical chemistry 1999 Dec;45(12):2293-4
Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy.
Nakaura H, Morimoto S, Yanaga F, Nakata M, Nishi H, Imaizumi T, Ohtsuki I
The American journal of physiology 1999 Aug;277(2 Pt 1):C225-32
The American journal of physiology 1999 Aug;277(2 Pt 1):C225-32
Human cardiac troponin I: precise identification of antigenic epitopes and prediction of secondary structure.
Ferrieres G, Calzolari C, Mani JC, Laune D, Trinquier S, Laprade M, Larue C, Pau B, Granier C
Clinical chemistry 1998 Mar;44(3):487-93
Clinical chemistry 1998 Mar;44(3):487-93
No comments: Submit comment
No validations: Submit validation data